Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that has spread to the bone from another, primary anatomic site. Bone is one of the most frequent sites of metastatic carcinoma. Common sites of origin include lung, breast, and prostate.
Biomarker and diagnostic research for metastatic carcinoma in the bone has been reported in the published literature.
No clinical trials have been registered for metastatic carcinoma in the bone.
202 publications have been identified in PubMed for metastatic carcinoma in the bone. Kisho has analyzed 142 by research type. Research spans Epidemiology / Natural History (23%), Review / Meta-Analysis (20%), and Clinical Trial Publication (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 33 | 23% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:07 PM UTC
Research summaries |
29 |
20% |
Clinical study results | 27 | 19% |
Laboratory research | 22 | 15% |
Testing and diagnosis research | 15 | 11% |
Patient case studies | 15 | 11% |
New treatment approaches | 1 | 1% |
Zarba M (2026). [PMID: 41984479](https://pubmed.ncbi.nlm.nih.gov/41984479/). *JAMA Netw Open*. [Basic Science / Preclinical]
Martín-Quesada AI (2026). [PMID: 41740233](https://pubmed.ncbi.nlm.nih.gov/41740233/). *Semin Oncol*. [Review / Meta-Analysis]
Zou J (2026). [PMID: 42007522](https://pubmed.ncbi.nlm.nih.gov/42007522/). *Cell Biochem Funct*. [Review / Meta-Analysis]
Katayeu Y (2026). [PMID: 41330806](https://pubmed.ncbi.nlm.nih.gov/41330806/). *Semin Nucl Med*. [Review / Meta-Analysis]
Nakai Y (2025). [PMID: 41027468](https://pubmed.ncbi.nlm.nih.gov/41027468/). *Open biology*. [Review / Meta-Analysis]
Lan B (2025). [PMID: 40634407](https://pubmed.ncbi.nlm.nih.gov/40634407/). *Sci Rep*. [Basic Science / Preclinical]
Rai P (2025). [PMID: 40304669](https://pubmed.ncbi.nlm.nih.gov/40304669/). *AJR. American journal of roentgenology*. [Review / Meta-Analysis]
Gómez-Benlloch A (2025). [PMID: 40791802](https://pubmed.ncbi.nlm.nih.gov/40791802/). *Case reports in ophthalmology*. [Case Report / Case Series]
Murphy C (2025). [PMID: 41114991](https://pubmed.ncbi.nlm.nih.gov/41114991/). *JAMA*. [Review / Meta-Analysis]
Avancini A (2025). [PMID: 40198943](https://pubmed.ncbi.nlm.nih.gov/40198943/). *Lung Cancer*. [Diagnostic / Biomarker]
AI-curated news mentioning metastatic carcinoma in the bone
Updated Apr 23, 2026
A recent study highlights hidradenoma in axillary lymph nodes as a potential diagnostic pitfall that can be mistaken for metastatic carcinoma. This finding underscores the importance of accurate diagnosis in rare tumors.